sodium salicylate has been researched along with 16,16-dimethylprostaglandin e2 in 5 studies
Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (16,16-dimethylprostaglandin e2) | Trials (16,16-dimethylprostaglandin e2) | Recent Studies (post-2010) (16,16-dimethylprostaglandin e2) |
---|---|---|---|---|---|
2,031 | 50 | 171 | 542 | 22 | 14 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kasdon, E; Marrone, G; Rowe, PH; Silen, W; Starlinger, MJ | 1 |
Cook, GA; Elliott, SL; Giraud, AS; Skeljo, MV; Yeomans, ND | 1 |
Barnes, CJ; Cameron, IL; Hardman, WE; Lee, M | 1 |
Ehrlich, K; Gretzer, B; Lambrecht, N; Maricic, N; Peskar, BM; Respondek, M | 1 |
Ehrlich, K; Peskar, BA; Peskar, BM | 1 |
5 other study(ies) available for sodium salicylate and 16,16-dimethylprostaglandin e2
Article | Year |
---|---|
Effect of simulated systemic administration of aspirin, salicylate, and indomethacin on amphibian gastric mucosa.
Topics: 16,16-Dimethylprostaglandin E2; 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Dinoprost; Dinoprostone; Electrophysiology; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Indomethacin; Metiamide; Prostaglandins; Prostaglandins E; Prostaglandins F; Rana catesbeiana; Sodium Salicylate; Time Factors | 1986 |
Repair of rat gastric mucosa: effect of 16,16-dimethyl prostaglandin E2.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Central Nervous System Depressants; Drug Evaluation, Preclinical; Ethanol; Gastric Acidity Determination; Gastric Mucosa; Hydrogen-Ion Concentration; Male; Random Allocation; Rats; Rats, Wistar; Sodium Salicylate; Stomach Diseases; Time Factors | 1997 |
Aspirin, but not sodium salicylate, indomethacin, or nabumetone, reversibly suppresses 1,2-dimethylhydrazine-induced colonic aberrant crypt foci in rats.
Topics: 1,2-Dimethylhydrazine; 16,16-Dimethylprostaglandin E2; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Butanones; Carcinogens; Colon; Colonic Neoplasms; Cyclooxygenase Inhibitors; Dimethylhydrazines; Indomethacin; Male; Nabumetone; Rats; Rats, Sprague-Dawley; Sodium Salicylate | 1997 |
Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Blood Platelets; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dexamethasone; Dimercaprol; Eicosanoids; Ethanol; Gastric Mucosa; Iodoacetamide; Irritants; Isoenzymes; Lithium; Male; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Sodium Salicylate; Sulfonamides | 1998 |
Role of ATP-sensitive potassium channels in prostaglandin-mediated gastroprotection in the rat.
Topics: 16,16-Dimethylprostaglandin E2; Adaptation, Physiological; Adenosine Triphosphate; Administration, Oral; Animals; ATP-Binding Cassette Transporters; Dimercaprol; Dose-Response Relationship, Drug; Ethanol; Gastric Mucosa; Glyburide; KATP Channels; Lithium Chloride; Male; Maleates; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Prostaglandins; Rats; Rats, Wistar; Sodium Salicylate; Stomach Ulcer | 2002 |